- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06341049
Effect of Three Different Postcesarean Analgesic Techniques on QbsQor-10 Score: Prospective, Randomized Trial
March 25, 2024 updated by: Aysenur Dostbil, Ataturk University
Effect of Three Different Postcesarean Analgesic Techniques on ObsQoR-10 Score: Prospective, Randomized Trial
The aim of this study is to evaluate the effects of three different postsesarean analgesia techniques, including instillation of local anesthetic into the peritoneum with infiltration into all layers of the anterior abdominal wall, intrathecal morphine injection with local anesthetic, and quadrotus lumborum type 1 block, on the postoperative recovery of women using the ObsQoR-10 score..
Study Overview
Status
Recruiting
Conditions
Detailed Description
This study will be planned on women who will undergo elective cesarean section surgery with neuraxial anesthesia, after obtaining ethics committee approval and written informed consent from the patients.Parturients will be randomized by the statistician using a computerized random numbers table and divided into 3 equal groups: Group IPLA + LWI, Group QLB 1 and Group M.Postoperatively, patients' ObsQoR-10 scores will be evaluated and recorded at the 24th and 48th hours.
Study Type
Interventional
Enrollment (Estimated)
45
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Aysenur Dostbil
- Phone Number: +905333676696
- Email: adostbil@hotmail.com
Study Contact Backup
- Name: Mehmet Akif Yılmaz
- Phone Number: +905346533539
- Email: mehmetakifyilmaz025@gmail.com
Study Locations
-
-
Palandoken
-
Erzurum, Palandoken, Turkey
- Recruiting
- Ataturk University
-
Contact:
- Aysenur Dostbil
- Phone Number: +905333676696
- Email: adostbil@hotmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Elective cesarean section under spinal anesthesia
- Full-term singleton pregnancy
- Agree to participate in the study
- American Society of Anaesthesiology Score of II
Exclusion Criteria:
- Contrindication for neuraxial anesthesia
- ASA≥3, diabetes, preeclampsia, cardiovascular disease, chronic pain and neuropathic pain
- Age< 18 or > 50
- Multiple pregnancy
- Presence of psychiatric diseases
- Gave a history of allergic to any medication in the study protocol
- Gave a history of chronic pain
- Unable to consent
- BMI>35 kg/m2
- Those who were given opioids during the operation due to intraoperative pain
- Those who have had previous abdominal surgery
- Patients who failed spinal anesthesia and switched to general anesthesia
- Those who have excessive bleeding or uterine atony during the operation
- Does not understand VAS
- Those who have a drain placed in the area to be infiltrated
- Gave a history of drug addiction
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Group Intraperitoneal local anasthetic+ loal anesthetic wound infiltration
For Group Intraperitoneal local anasthetic+ loal anesthetic wound infiltration, after the birth of the newborn and placenta, the uterus is taken out and closed, the blood accumulated in the pelvis is carefully wiped with surgical towels, and after complete hemostasis is achieved, sterilely prepared 20 ml 0.5% bupivacaine + 20 ml 2% lidocaine +1 A total of 40 ml of solution containing 200,000 epinephrine will be given to the surgeon.
10 ml of this solution will be instilled into all four quadrants of the uterus before closing the parietal peritoneum or fascia.
The parietal peritoneal layer will be sutured or left open, depending on the surgeon's preference.
10 ml will be infiltrated around the edges of the rectus aponeurosis, and the remaining 20 ml will be infiltrated subcutaneously into the wound area.
|
For Group Intraperitoneal local anasthetic+ loal anesthetic wound infiltration, after the birth of the newborn and placenta, the uterus is taken out and closed, the blood accumulated in the pelvis is carefully wiped with surgical towels, and after complete hemostasis is achieved, sterilely prepared 20 ml 0.5% bupivacaine + 20 ml 2% lidocaine +1 A total of 40 ml of solution containing 200,000 epinephrine will be given to the surgeon.
10 ml of this solution will be instilled into all four quadrants of the uterus before closing the parietal peritoneum or fascia.
The parietal peritoneal layer will be sutured or left open, depending on the surgeon's preference.
10 ml will be infiltrated around the edges of the rectus aponeurosis, and the remaining 20 ml will be infiltrated subcutaneously into the wound area.
|
Active Comparator: Group Morphine
Group Morphine will be given 11.2 mg hyperbaric bupivacaine + 15 µg fentanyl + 150 µg morphine into the spinal space.
|
Group Morphine will be given 11.2 mg hyperbaric bupivacaine + 15 µg fentanyl + 150 µg morphine into the spinal space.
|
Active Comparator: Group Quadratus lumborum block
In Group Quadratus lumborum block, Quadratus lumborum block type I, a total of 40 ml of a solution containing 20 ml of 0.5% bupivacaine + 20 ml of 2% lidocaine + 1:200,000 epinephrine will be applied bilaterally under ultrasound guidance.
|
In Group Quadratus lumborum block, Quadratus lumborum block type I, a total of 40 ml of a solution containing 20 ml of 0.5% bupivacaine + 20 ml of 2% lidocaine + 1:200,000 epinephrine will be applied bilaterally under ultrasound guidance.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
obstetric quality of recovery-10 (ObsQoR-10) scores of parturient at the 24th and 48th postoperative hours
Time Frame: Postoperative 24th and 48th hours
|
For post-cesarean analgesia, patients will receive instillation of local anesthetic into the peritoneum with infiltration into all layers of the anterior abdominal wall, intrathecal morphine injection with local anesthetic, and quadrotus lumborum type 1 block.
ObsQoR-10 scores of the patients will be evaluated at the 24th and 48th hours postoperatively.
|
Postoperative 24th and 48th hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Aysenur Dostbil, Ataturk University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 12, 2024
Primary Completion (Estimated)
June 12, 2024
Study Completion (Estimated)
September 12, 2025
Study Registration Dates
First Submitted
March 19, 2024
First Submitted That Met QC Criteria
March 25, 2024
First Posted (Actual)
April 2, 2024
Study Record Updates
Last Update Posted (Actual)
April 2, 2024
Last Update Submitted That Met QC Criteria
March 25, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2024-03/14
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postoperative Recovery
-
American University of Beirut Medical CenterCompletedShivering | Postoperative Recovery | Anesthesia Recovery | Anesthesia EmergenceLebanon
-
Alkahest, Inc.CompletedPostoperative RecoveryUnited States
-
Zhihong LUCompleted
-
Cairo UniversityUnknown
-
Fujian Provincial HospitalCompletedPostoperative RecoveryChina
-
Cukurova UniversityCompleted
-
Avicenna Military HospitalCompletedPostoperative RecoveryMorocco
-
Eunah Cho, MDCompletedPostoperative RecoveryKorea, Republic of
-
Third Affiliated Hospital, Sun Yat-Sen UniversityRecruitingMicrobiota | Postoperative RecoveryChina
-
China National Center for Cardiovascular DiseasesRecruitingPostoperative RecoveryChina
Clinical Trials on Intraperitoneal local anasthetic application + local anesthetic wound infiltration
-
University of PadovaRecruitingPain, Postoperative | Anesthesia, Local | Surgery | Opioid UseItaly
-
Dr Muhammad ArifRecruiting
-
Ottawa Hospital Research InstituteUnknown
-
University of California, DavisRecruitingOpioid Use | Post Operative Pain | Nausea and Vomiting, PostoperativeUnited States
-
Lithuanian University of Health SciencesUnknownPrimary Total Knee ArthroplastyLithuania
-
University of SaskatchewanCompletedCarpal Tunnel Syndrome | Carpal TunnelCanada
-
Cairo UniversityCompletedObstetric Pain | Obstetric Anesthesia ProblemsEgypt
-
Cairo UniversityCompletedObstetric Pain | Obstetric Anesthesia ProblemsEgypt
-
Universiteit AntwerpenCompleted